Nephron recalls specific injections due to lack of sterility assurance. Products may cause infections if used. Stop using and contact for details.
Lack of Assurance of Sterility
Nephron is recalling certain bupivacaine, ketorolac, and ketamine injections that may not be sterile. Using these products could lead to infections, especially in medical settings.
The injections lack proper sterility assurance, meaning they could contain harmful bacteria. This poses a risk of infection if used in medical procedures, particularly in sterile environments.
Healthcare professionals and patients using the recalled injections for medical procedures. Those with the specific NDC numbers and expiration dates are most at risk.
Check for the NDC number 69374-514-50 on the packaging. The products were manufactured in batches BP2001A, BP2002A, or BP2007A with specific expiration dates.
Discontinue use of the recalled injections if you have them.
The NDC number is 69374-514-50.
Batches BP2001A (exp. 7/6/2022), BP2002A (exp. 7/27/2022), and BP2007A (exp. 7/3/2022).
Check the packaging for the NDC number 69374-514-50 and the specific batch numbers listed.
We’ve drafted a message you can send Nephron to request your refund or repair — edit it as you like.
Subject: Recall D-1249-2022 — Nephron Nephron Hello, I own a Nephron that is covered by recall D-1249-2022 from Nephron. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
